One of Keating’s better presentations. It clearly demonstrated...

One of Keating’s better presentations.

It clearly demonstrated that with technical progress, regulatory approvals and partnerships already in place, ResApp Health is worth vastly more than the measly $130M being offered by Pfizer.

If I vote Yes I will be supporting the sale of my holdings at about 10% of their true current value.

Vote NO and I will retain the opportunity to realise that true value and more as further growth is achieved in future.

Simple choice really.

IMO